Paper9214432
Adenosine A1 receptor promotion of multinucleated giant cell formation by human monocytes: a mechanism for methotrexate-induced nodulosis in rheumatoid arthritis.
Merrill JT and 8 others. Arthritis Rheum, 1997. Cited by 117 papers, by iCite.
Cite this record
ConductScience Library. Adenosine A1 receptor promotion of multinucleated giant cell formation by human monocytes: a mechanism for methotrexate-induced nodulosis in rheumatoid arthritis. Papers, record 9214432. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9214432
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antirheumatic Agents | Major topic |
| Arthritis, Rheumatoid | Major topic |
| Methotrexate | Major topic |
| Monocytes | Major topic |
| Receptors, Purinergic P1 | Major topic |
| Rheumatoid Nodule | Major topic |
| Adenosine | |
| Cells, Cultured | |
| Humans | |
| Tetradecanoylphorbol Acetate | |
| Theobromine | |
| Xanthines |
Source PubMed
Grants5
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| AR-11949 | NIAMS NIH HHS | United States | R01AR011949 | PubMed and NIH | NIH RePORTER |
| AR/AI-41911 | NIAMS NIH HHS | United States | PubMed | PubMed | |
| K08-AI-01215 | NIAID NIH HHS | United States | K08AI001215 | PubMed and NIH | NIH RePORTER |
| R01AR041911 | NIH | NIH RePORTER | |||
| R37AR011949 | NIH | NIH RePORTER |
Cited by54
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 117 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42368991 | Regression and Disappearance of Accelerated Nodulosis with Adalimumab. | Mediterr J Rheumatol | 2026 | https://conductscience.org/library/papers/42368991 | PubMed |
| 42368981 | Extensive Subcutaneous Rheumatoid Nodules Reflecting High Burden of Disease Activity. | Mediterr J Rheumatol | 2026 | https://conductscience.org/library/papers/42368981 | PubMed |
| 39886296 | Methotrexate-Induced Accelerated Nodulosis: A Case Series. | Mediterr J Rheumatol | 2024 | https://conductscience.org/library/papers/39886296 | PubMed |
| 37888090 | Cutaneous Manifestations of Rheumatoid Arthritis: Diagnosis and Treatment. | J Pers Med | 2023 | https://conductscience.org/library/papers/37888090 | PubMed |
| 36422501 | Outcome of solid and cavitary pulmonary nodules in rheumatoid arthritis patients-case series. | Turk J Med Sci | 2022 | https://conductscience.org/library/papers/36422501 | PubMed |
| 36064866 | The role of adenosine A1 receptor on immune cells. | Inflamm Res | 2022 | https://conductscience.org/library/papers/36064866 | PubMed |
| 35410356 | Adenosine inhibits TNFα-induced MMP-3 production in MH7A rheumatoid arthritis synoviocytes via A2A receptor signaling. | Sci Rep | 2022 | https://conductscience.org/library/papers/35410356 | PubMed |
| 35068924 | Mécanisme d'action du méthotrexate dans le traitement de la polyarthrite rhumatoïde. | Rev Rhum Ed Fr | 2020 | https://conductscience.org/library/papers/35068924 | PubMed |
| 34975886 | Pharmacomicrobiology of Methotrexate in Rheumatoid Arthritis: Gut Microbiome as Predictor of Therapeutic Response. | Front Immunol | 2021 | https://conductscience.org/library/papers/34975886 | PubMed |
| 32501738 | Noninfectious Granulomatous Diseases of the Chest. | Radiographics | 2020 | https://conductscience.org/library/papers/32501738 | PubMed |
| 32103295 | Protective effects of hesperidin against MTX-induced hepatotoxicity in male albino rats. | Naunyn Schmiedebergs Arch Pharmacol | 2020 | https://conductscience.org/library/papers/32103295 | PubMed |
| 32066940 | Methotrexate and its mechanisms of action in inflammatory arthritis. | Nat Rev Rheumatol | 2020 | https://conductscience.org/library/papers/32066940 | PubMed |
| 31658782 | Methotrexate an Old Drug with New Tricks. | Int J Mol Sci | 2019 | https://conductscience.org/library/papers/31658782 | PubMed |
| 31497770 | Accelerated Nodulosis in a Patient With Rheumatoid Arthritis. | Arch Rheumatol | 2019 | https://conductscience.org/library/papers/31497770 | PubMed |
| 31234425 | The Adenosine A2B Receptor Drives Osteoclast-Mediated Bone Resorption in Hypoxic Microenvironments. | Cells | 2019 | https://conductscience.org/library/papers/31234425 | PubMed |
| 30081197 | Methotrexate mechanism in treatment of rheumatoid arthritis. | Joint Bone Spine | 2019 | https://conductscience.org/library/papers/30081197 | PubMed |
| 28405546 | Arthropathy in Dermatology: A Comprehensive Review. | Indian Dermatol Online J | 2017 | https://conductscience.org/library/papers/28405546 | PubMed |
| 27883999 | Low Prevalence of Nodules in Rheumatoid Arthritis Patients in Kuwait: A Description and a Comparison of Patients from the Kuwait Registry for Rheumatic Diseases. | Med Princ Pract | 2017 | https://conductscience.org/library/papers/27883999 | PubMed |
| 27829671 | Adenosine and adenosine receptors in the pathogenesis and treatment of rheumatic diseases. | Nat Rev Rheumatol | 2017 | https://conductscience.org/library/papers/27829671 | PubMed |
| 27478398 | Rapid Growth of Lung Nodules due to Combined Pulmonary Vasculitis, Silicoanthracosis, and Chondrocalcinosis. | Can Respir J | 2016 | https://conductscience.org/library/papers/27478398 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| ADORA1 | 134 | PubTator's text mining | https://conductscience.org/library/genes/134 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/9214432
GET https://conductscience.org/api/papers/v1/9214432/cited_by?page=2